Lung Cancer Europe

Startseite
Schweiz
Bern
Lung Cancer Europe

Wegbeschreibung Website Kontaktieren Sie die Organisation

Kontaktinformationen, Karte und Wegbeschreibungen, Kontaktformulare, Öffnungszeiten, Dienstleistungen, Bewertungen, Fotos, Videos und Ankündigungen von Lung Cancer Europe, Nichtregierungsorganisation (NRO), Effingerstrasse 40, Bern.

🌍 European network of lung cancer organisations
🫁 Turning evidence into advocacy
🔬 Earlier diagnosis & testing
💊 Equal access to lung cancer treatment & care
🤝 Better support for people affected by lung cancer
🇪🇺 Working for change across Europe

14/10/2026

The Biotech Act is a new EU law proposed by the European Commission to speed up health biotechnology in Europe, including changes to how clinical trials are run.

On 12 October, our President Debra Montague and Vice President Angeliki Souri represented Lung Cancer Europe at an expert dialogue on the Act at the European Parliament in Brussels, hosted by the Intergroup on Cancer and Rare Diseases.

We welcome faster progress in health biotechnology. But the Act will only help people with lung cancer if new treatments and tests reach them in every EU country.

Our position sets out six changes we're asking for. They include biomarker testing people can actually get, and a funded role for patient organisations in how the Act is run.

Read more: https://lungcancereurope.eu/news/eu-biotech-act-position-brussels-dialogue

13/10/2026

Today, Debra Montague, President of Lung Cancer Europe, is joining European experts for an online discussion on screening and early detection.

The session looks at what it actually takes to put national lung cancer screening into practice: what countries are learning, where the gaps remain and how policy can translate into real access.

That’s especially important as screening moves forward at different speeds across Europe. Evidence matters, but so do implementation, follow-up and making sure eligible people can access high-quality screening wherever they live.

📅 13 October 2026
🕙 10:00–11:00 CEST
💻 Online

Debra will join speakers from the EFPIA Oncology Platform, the European Observatory on Health Systems and Policies and SOLACE.

Register via the link in our story.

12/10/2026

Last week, Belgium's Deputy Prime Minister and Health Minister Frank Vandenbroucke announced a new 10-year Cancer Plan, with 34 measures covering prevention, early detection and treatment.

From 2028, complex lung cancer care will be further concentrated in specialised reference centres. Belgium already uses this model for oesophageal, pancreatic, and head and neck cancers.

The plan will also create a national multidisciplinary expert panel to support difficult treatment decisions, bringing experienced specialists together through a national Molecular Tumour Board.

There's a lot here that could strengthen lung cancer care: more specialist input, better coordination and more consistent access to expertise.

How it works in practice will be important. Concentrating complex care should improve quality without making access harder for people who live further from a specialist centre or already face barriers to care.

That balance is important across Europe. People affected by lung cancer should have access to high-quality specialist care, wherever they live.

11/10/2026

Pope Leo XIV has just announced that doctors have found a “localised nodule” in his lung and that he’ll undergo surgery to remove it in the coming days. The Vatican says the lesion is at an early, circumscribed stage.

By speaking about it publicly, he’s also brought a term many people come across in scan reports into the conversation.

A lung nodule is a small area seen on a scan. Most lung nodules are not cancer, but some can be, which is why they need proper assessment.

“Localised”, “circumscribed” or “well defined” describe what a nodule looks like or where it is. They do not, on their own, tell us whether it’s benign or could be cancer.

Doctors usually look at several things together, including the nodule’s size, shape and appearance, whether it has changed over time, previous scans and the person’s individual risk factors.

Sometimes the next step is another scan. Sometimes more tests or surgery are recommended. A description on a scan is only one part of the picture.

There has been no diagnosis announced in Pope Leo’s case, so it would be wrong to speculate beyond what has been made public.

It is good to see lung health being talked about openly. Lung conditions can still come with fear, assumptions and stigma, and straightforward conversations can help make it easier for people to ask questions and seek care.

We wish Pope Leo well for his surgery and recovery.

10/10/2026

Poland is putting nationwide lung cancer screening into practice.

A new publicly funded programme is starting this month, using low-dose CT to help find lung cancer earlier in people at higher risk.

The first appointments are expected from the second half of October. The programme is designed to be available across all 16 regions, with no referral needed for eligible people.

This is an important step for early detection in Europe. Lung cancer screening should not depend on where someone lives, and programmes need to reach people at risk in a clear, consistent and accessible way.

09/10/2026

Lung cancer prevention also means reducing harmful exposure at work.

This week, the European Parliament backed stronger rules to protect workers from cancer-causing substances.

The European Commission estimates that stronger EU workplace protections could prevent around 1,700 lung cancer cases across the EU over the next 40 years.

Workplace exposure to known carcinogens is still a real issue across Europe, from diesel exhaust and silica to welding fumes, asbestos and some metals.

The rules aren’t in full force yet. The Council still needs to formally adopt them, and Member States will then need to bring them into national law.

Find out more about what’s changed, which workplace exposures are linked to lung cancer and why lung cancer prevention also means preventing exposure 🔗 in comments.

06/10/2026

This is the final week to take part in our 12th Annual Report Survey - it will close on 14 October.

We want to hear from people living with lung cancer and their loved ones about quality of life and support needs.

If you are eligible, please take the survey. If you have already taken part, please share it with someone else who may be able to.

The survey takes around 15 to 20 minutes and responses are treated confidentially.

Please take part 🔗 https://es.surveymonkey.com/r/LungCancerEuropeSurvey2026

02/10/2026

Lung cancer can have a significant impact on mental health as well as physical health.

In our 10th Annual Report, 61.2% of participants reported a negative impact on their mental health following a lung cancer diagnosis.

Fear was also a major theme. 76.7% feared that treatment might not work or that the cancer might progress, while 46.3% said emotional difficulties often or constantly interfered with daily functioning.

The findings came from 2,204 people affected by lung cancer across 31 European countries and show why mental health support needs to be part of lung cancer care.

Our Annual Reports collect evidence about the experiences and challenges faced by people affected by lung cancer across Europe, and use that evidence in our advocacy and policy work.

The survey for our 12th Report, looking at quality of life and support needs, is now open. If you are living with lung cancer or caring for someone who is, please take part via the link in comments.

29/09/2026

Today is World Heart Day. The link between lung cancer and heart health runs both ways.

The two conditions share risk factors. An existing heart condition can affect lung cancer treatment decisions, while some treatments can affect the heart.

Heart health must be considered when planning treatment and during follow-up. The checks needed will differ from person to person.

Read more about lung cancer and heart health at the link in our comments.

28/09/2026

What is a lung nodule?

It is a small spot seen on a lung scan. Most nodules found through lung cancer screening are not cancer. They can be caused by a past infection, inflammation or scarring.

The healthcare team looks at the size and appearance of a nodule and may compare scans over time. Some findings need further tests.

For people with lung cancer, a new nodule needs to be assessed in the context of their diagnosis, treatment and earlier scans. Their healthcare team can explain what the finding means for them.

The first EU Screening Week runs from 28 September to 4 October. It brings organisations across Europe together to raise awareness of prevention and early detection. Lung health is part of that conversation.

Adresse

Effingerstrasse 40
Bern
3008

Website

https://linktr.ee/lungcancereur

Benachrichtigungen

Erfahren Sie als Erste/r von Neuigkeiten und Aktionen: Wir schicken Ihnen eine E-Mail, wenn Lung Cancer Europe etwas veröffentlicht. Ihre E-Mail-Adresse wird für keinen anderen Zweck verwendet, und Sie können sich jederzeit abmelden.